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Abstract  
Hypoxia-induced coronary artery vasodilatation protects the heart by increasing blood 
flow under ischemic conditions, however its mechanism is not fully elucidated. 
Hydrogen sulfide (H2S) is reported to be an oxygen sensor/transducer in the 
vasculature. The present study aimed to identify and characterise the role of H2S in the 
hypoxic response of the coronary artery, and to define the H2S synthetic enzymes 
involved. Immunoblotting and immunohistochemistry showed expression of all three 
H2S-producing enzymes, cystathionine-ß-synthase (CBS), cystathionine-γ-lyase 
(CSE) and 3-mercaptopyruvate sulfurtransferase (MPST), in porcine coronary artery. 
Artery segments were mounted for isometric tension recording; hypoxia caused a 
transient endothelium-dependent contraction followed by prolonged endothelium-
independent relaxation. The CBS inhibitor amino-oxyacetate (AOAA) reduced both 
phases of the hypoxic response. The CSE inhibitor DL-propargylglycine (PPG) and 
aspartate (limits MPST) had no effect alone, but when applied together with AOAA 
the hypoxic relaxation response was further reduced. Exogenous H2S (Na2S and 
NaHS) produced concentration-dependent contraction followed by prolonged 
relaxation. Responses to both hypoxia and exogenous H2S were dependent on the 
endothelium, NO, cGMP, K
+
 channels and Cl
-
/HCO3
-
 exchange. H2S production in 
coronary arteries was blocked by CBS inhibition (AOAA), but not by CSE inhibition 
(PPG). These data show that H2S is an endogenous mediator of the hypoxic response 
in coronary arteries. Of the three H2S-producing enzymes, CBS, expressed in the 
vascular smooth muscle, appears to be the most important for H2S generated during 
hypoxic relaxation of the coronary artery. A contribution from other H2S-producing 
enzymes only becomes apparent when CBS activity is inhibited. 
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1. Introduction 
 
In the heart, hypoxia due to ischemia is a dangerous insult which compromises cardiac 
function. Hypoxic coronary vasodilatation is an important pathophysiological 
response that increases blood flow to the heart and, therefore, oxygenation to the 
hypoxic or ischemic myocardium. Although extensively investigated, the mechanisms 
have not been fully elucidated. It has been reported that the gasotransmitter hydrogen 
sulfide (H2S), a novel signalling molecule found throughout the cardiovascular system 
as multiple forms (H2S, HS
-
, S
2-
) and polysulfides, may act as an oxygen 
sensor/transducer of the hypoxic response in the aorta and pulmonary arteries, with 
different enzymes involved in the synthesis of H2S during hypoxia amongst these 
tissues/species [1-3]. Little is known, however, about the role of H2S in the hypoxic 
response of the coronary artery.    
 
H2S is synthesised endogenously principally from L-cysteine by the enzymes 
cystathionine-ß-synthase (CBS) and cystathionine-γ-lyase (CSE), and by the 
sequential actions of cysteine aminotransferase (CAT) and 3-mercaptopyruvate 
sulfurtransferase (MPST) [1,4]. CSE and CBS are found in many tissues, with the 
consensus being that CSE is primarily located within the vasculature and CBS in the 
brain [5]. More recent evidence has shown that CBS and 3-MPST are also present in 
vascular endothelium and smooth muscle [6-8]. In the vasculature, H2S may cause 
vasoconstriction and/or vasodilation depending on factors including concentration and 
vessel origin, and the responses are oxygen-dependent [3,9,10]. Mice genetically 
devoid of CBS show a loss of hypoxia-induced vasodilation in cerebral microvessels 
illustrating the importance of this enzyme in the brain [11], and have elevated plasma 
homocysteine levels, which has been associated with the development of 
cardiovascular disease [12]. The effect of genetic deletion of CSE has been shown in 
some studies to produce lower H2S levels, hypertension and to reduce endothelium-
dependent vasorelaxation [13] but in others the CSE knockout mice were 
normotensive [14]. 
 
Studies of the mechanism of coronary hypoxic relaxation have shown an involvement 
of ATP-sensitive potassium (KATP) channels [15] and Kv7 channels [16]. Exogenous 
H2S-mediated coronary artery relaxations have also been shown to involve KATP, Kv7 
and BKCa channels [16-18]. However, the role of endogenous H2S in coronary 
hypoxic vasorelaxation has not been systematically investigated and which, if any, of 
the H2S synthesising enzymes is involved is unclear. There is a precedent for an 
important protective role of endogenous H2S in the ischemic heart, as an antioxidant 
and in affording protection against reperfusion injury [19-22]; if H2S is also identified 
as a hypoxic coronary vasodilator, this would increase its therapeutic potential in the 
treatment of heart disease. If treatments leading to upregulation of endogenous H2S 
are to be developed in order to offer protection to the heart from hypoxia (thereby 
preventing or reducing the symptoms of angina and heart failure), it is fundamental 
that the enzyme(s) involved in the enzymatic synthesis of H2S are identified. 
Accordingly, the aims of this study were to identify and characterise the role of 
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endogenous H2S in the coronary arterial response to hypoxia, and the H2S synthetic 
enzymes involved.  
 
2. Methods 
 
2.1 Tissue preparation 
All experimental procedures were approved by the Animal Care and Use Committee 
of University of Nottingham, United Kingdom. Pig hearts (either sex, age < 6 months, 
∼50 kg) were obtained on ice from a local abattoir (G Wood & Sons Ltd, Mansfield, 
UK). The left circumflex coronary artery was dissected and stored overnight at 4 °C in 
gassed (95% O2, 5% CO2) Krebs–Henseleit solution, as previously described [23]. 
The coronary artery was cut into rings of ~5 mm which were suspended in organ baths 
in gassed (95% O2, 5% CO2) Krebs–Henseleit solution. The endothelium of some 
arteries was removed by gentle rubbing [23]; successful removal was tested using 
substance P (10 nM) (control 75 ± 11%; endothelium removal 3 ± 2% (n = 8)). 
 
2.2 Responses in the porcine isolated coronary artery 
Arterial rings were mounted onto wires in 20 ml tissue baths and tensioned to 10 g. 
Each ring was attached to an isometric force transducer connected to a Powerlab with 
tension tension changes captured using LabChart software (ADInstruments, Sydney, 
Australia). Tissue viability was assessed using 60 mM KCl (2-3 additions). The 
thromboxane A2 analogue U46619 (11α,9α-epoxymethano-PGH2) was added to 
contract the vessels to ~50-60% (57 ± 1%, n = 144) of the final KCl response (6 ± 0.2 
nM U46619, n = 144; arteries in the presence of glibenclamide required a 10 x higher 
concentration, 55 ± 6 nM U46619, n = 24)  
 
2.3 Experimental protocols 
U46619 contracted vessels were exposed to hypoxia (95% N2/ 5% CO2) for 30 min. In 
separate experiments, concentration response curves were constructed to H2S donors 
(Na2S and NaHS). The effects of the CSE inhibitor DL-propargylglycine (PPG), CBS 
inhibitor amino-oxyacetate (AOAA), MPST pathway inhibition (aspartate; inhibits 
CAT activity), nitric oxide synthase inhibitor (L-NAME), endothelium removal, 
soluble guanylyl cyclase inhibitor (ODQ), adenylyl cyclase inhibitor (SQ22536), Cl
-
/HCO3
-
 exchange inhibitor (4,4'-diisothiocyano-2,2'-stilbenedisulfonic acid, DIDS), 
high K
+
 (50 mM), non-selective K
+
 channel blocker (tetraethylammonium, TEA) and 
inhibitors of KIR (BaCl2), KCa (charybdotoxin, intermediate and large conductance 
Ca
2+
-activated K channel inhibitor; TRAM-34, intermediate conductance Ca
2+
-
activated K channel inhibitor; apamin, small conductance Ca
2+
-activated K channel 
inhibitor), KV (4-AP) and KATP (glibenclamide) channels were examined by 
application prior to the addition of U46619, which ensured a minimal contact time of 
1h prior to induction of hypoxia or H2S application. For each of the different 
experimental conditions separate control experiments were carried out on vessel 
segments from the same coronary arteries.  
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2.4 Cultured porcine coronary artery smooth muscle cells 
 
Porcine coronary arteries were dissected and stored overnight at 4 °C in gassed (95% 
O2, 5% CO2) Krebs–Henseleit solution containing 1X antibiotic antimycotic solution 
(100 units penicillin, 0.10 mg streptomycin and 0.25 μg amphotericin B per ml) 
(Antibiotic Antimycotic Solution (100×), A5955, Sigma-Aldrich, Dorset, UK). The 
next day, PCAs were finely dissected and cut open longitudinally. The vessels were 
then washed 3x with 5 ml DMEM (D6429, Sigma-Aldrich, Dorset, UK) containing 
1X antibiotic antimycotic solution in a 30 ml universal tube. To isolate smooth muscle 
cells, each vessel was incubated at 37 °C for 40 min in a 1.5 ml Eppendorf containing 
1 ml DMEM with type II collagenase (2mg/mL, C6885, Sigma-Aldrich, Dorset, UK) 
[24]. Each vessel was then washed twice with 1 ml DMEM, 1X antibiotic antimycotic 
solution. In the third wash, to isolate the smooth muscle cells, the mixture was vortex 
and pipetted onto a (60 mm Costar) Petri dish and 5 ml of DMEM containing 1X 
antibiotic antimycotic solution, L-glutamate (59202C, Sigma-Aldrich, Dorset, UK) 
and FBS (F6178, Sigma-Aldrich, Dorset, UK) were added. At day 6, cells were split 
onto cover slips for immunocytochemistry and onto 24-well plates for immunoblot 
studies.  
 
2.5 Immunohistochemistry 
 
Tissue sections were fresh frozen in OCT using liquid nitrogen cooled isopentane. 
Sections were cut using a cryostat (Leica CM1900) and applied to APES slides (20 
µm). Staining was achieved using a VECTASTAIN Elite ABC Kit Cat no. PK6100 
Series (Vector Laboratories Inc., US). Briefly sections were fixed (acetone, 4
o
C) and 
quenched for endogenous peroxidase (0.3% H2O2 0.3% normal serum in PBS). Tissue 
was then incubated with 2% normal blocking serum followed by incubation with 
primary antibody (1 µl per 500ml MPST, 1.5 µl CBS/CSE in 500 ml PBS with 1 % 
BSA) and left at 4
o
C overnight. The tissue was then incubated with the biotinylated 
secondary antibody at room temperature. A further peroxidase quenching step was 
performed followed by incubation with VECTASTAIN
®
 Elite
®
 ABC reagent. The 
tissue was then incubated with DAB for ~2 min, rinsed and mounted (95 % glycerol/5 
% distilled water). Sections were imaged using a light microscope (Leica DM4000 B 
LED). 
 
2.6 Immunocytochemistry for the expression of CBS enzyme in cultured porcine 
coronary artery smooth muscle cells 
 
Immunocytochemistry was carried out once the primary culture was confluent after ~3 
days. The SMCs were washed with ice cold PBS and then fixed with 4% PFA at RT 
for 30 min. The SMCs were then permeabilised using 0.15% Triton (T9284, Sigma-
Aldrich, Poole, UK) at RT for a further 30 min followed by blocking with 5% milk in 
PBS for 1 h. The SMCs were incubated in a humidifier at 4°C overnight with primary 
mouse monoclonal anti-actin α-smooth muscle antibody (A5228, Sigma-Aldrich, 
Dorset, UK) (1:200) and rabbit anti-CBS (1:200) (H00000875-D01P). The SMCs 
were washed 3x with PBS and incubated with TRITC goat anti-rabbit secondary 
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antibody (1:200) (A16101, Thermo Fisher Scientific, Waltham, MA U.S.A) and goat 
anti-rabbit FITC conjugated secondary antibody (1:200) (AP307F, Sigma-Aldrich, 
Dorset, UK) at RT for 45 min. The SMCs were then washed once with PBS then 
nuclear stain with DAPI (1µg/ml) for 5 min and then washed 3x with PBS followed 
by distilled water once. The SMCs were imaged using Leica DMRB fluorescent 
microscope.  
 
2.7 Immunoblotting 
 
Coronary arteries were dissected and frozen on dry ice. Segments were then 
homogenized in lysis buffer [20 mM Tris, 1 mM EGTA, 320 mM sucrose, 0.1% (v/v) 
Triton X-100, 1 mM NaF, 10 mM β-glycerophosphate, pH 7.6], containing protease 
inhibitor cocktail tablets, EDTA free. The protein concentration in each sample was 
assessed using the Bradford method and normalised. Samples, with 6× solubilization 
buffer [24% (w/v) SDS, 30% (v/v) glycerol, 5% (v/v) β-mercaptoethanol, 2.5% (v/v) 
bromophenol blue, 1.5 M Tris–HCl, pH 6.8], were heated at 95 °C for 5 min. 
Subsequently, electrophoresis was carried out on 4–20% Tris-glycine PAGE Gold 
Precast Gels (Bio-Rad, Hercules, CA, USA), with approximately 5 μg protein per 
lane. Samples were transferred to nitrocellulose membranes, which were incubated in 
blocking solution [6% fish skin gelatin in Tris-buffered saline containing 0.1% (v/v) 
Tween 20 (TBS-T)] for 1h at room temperature. Blots were incubated with primary 
antibodies: rabbit anti-CSE (1:1000) (ab80643) rabbit anti-CBS (1:1000) 
(H00000875-D01P) rabbit anti-MPST (1:1000) (HPA001240) and mouse monoclonal 
anti-β-actin (1:40,000) (A2228) diluted in blocking solution at 4°C overnight. After 
washing in TBS-T, the blots were incubated with an appropriate IRDye®-conjugated 
secondary antibody (Li-Cor Biosciences, Biotechnology, Lincoln, NE, USA) at 37°C 
for 1h. Proteins were visualized and quantified using the Li-Cor/Odyssey infrared 
imaging system.  
 
2.8 Endogenous production of H2S 
 
Segments of porcine coronary artery were homogenized in ice-cold Tris-EDTA buffer 
(50 mM, 1 mM, pH 7.4) and centrifuged at 4°C at 1000× g for 20 min. The 
supernatant was removed and centrifuged at 30 000× g at 4°C for 60 min. The 
supernatant layer was removed and assessed for H2S production using the methylene 
blue method [25]. Briefly samples were incubated with 1 mM pyridoxal phosphate in 
the absence and presence of 10 µM PPG or AOAA for 15 min at 37°C in a shaking 
water bath. 10 mM L-cysteine was added and the samples were incubated for 90 min. 
As a control, blank samples were prepared using Tris-EDTA buffer containing 
pyridoxal phosphate and L-cysteine, but no tissue (tissue blanks); and tissue samples 
containing pyridoxal phosphate, but no L-cysteine (substrate blanks). Reactions were 
stopped by the addition of 0.5 M NaOH followed by 4% (w/v) zinc acetate in distilled 
water and kept on ice for 30 min. A colorimetric change was achieved by addition of 
0.1% (w/v) dimethylphenylene-diamine sulphate in 5 M HCl and 50 mM ferric 
chloride. Samples were mixed and then centrifuged at 5000× g to clear the 
precipitated protein. After 20 min, samples were analysed at 670 nm.  
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MPST activity was examined by measuring H2S production from 3-mercaptopyruvate 
[25]. Porcine coronary artery homogenates were prepared as described above. In 
duplicate, supernatant samples were incubated with 0.3 mM 3-mercaptopyruvate and 
0.5 mM dithiothreitol in Tris buffer (0.1 M, pH 9.0) in a total volume of 150 µL in a 
shaking water bath at 37°C for 30 min. Reactions were stopped and H2S production 
were estimated using the methylene blue method as described above.  
2.9 Data analysis 
 
Data derived from the use of H2S salts (Na2S, NaHS) were expressed as log 
concentration–response plots with contractions/relaxations expressed as a percentage 
of the U46619 response. Hypoxic responses were measured in grams (g) and area 
under the curve was also measured. Responses to hypoxia, pinacidil and substance P 
were expressed as a percentage of the U46619 response. Data shown are mean ± SEM 
and were assessed for statistical significance via two-way ANOVA with Bonferroni 
post-test, Student’s t-test or one-way ANOVA with Tukey’s post-test (Prism; 
GraphPad, San Diego, CA, USA). Differences were considered as significant when 
P<0.05, where n is the number of animals. 
 
2.10 Materials  
 
Krebs–Henseleit buffer (mM): NaCl 118, KCl 4.8, CaCl2·H2O 1.3, NaHCO3 25.0, 
KH2PO4 1.2, MgSO4·1.2 and glucose 11.1 (Fisher, Loughborough). U46619 (Tocris 
Bioscience, Bristol) was dissolved in ethanol at 10 mM, then diluted in distilled water. 
Stock solutions of PPG, AOAA, aspartic acid, L-NAME, 4-AP, BaCl2, TEA (Sigma-
Aldrich, Poole Dorset) and substance P and ChTX (Tocris Bioscience, Bristol UK) 
were prepared in distilled water. Stock solutions of ODQ, SQ22536, apamin, 
glibenclamide, TRAM-34 and DIDS were prepared in DMSO. NaHS and Na2S were 
made immediately before application and kept on ice. Pinacidil (Sigma-Aldrich) was 
dissolved in DMSO as a 10 mM stock concentration, and then further dilutions made 
in distilled water. Primary antibodies for immunohistochemistry and Western blotting 
were from: CSE (ab80643; rabbit polyclonal) Abcam
®
 (Cambridge, UK); CBS 
(H00000875-D01P; rabbit polyclonal) Abnova (Taipei, Taiwan); MPST 
(HPA001240; rabbit polyclonal) and β-actin (mouse monoclonal) Sigma-Aldrich 
(Poole, Dorset, UK).  
 
3. Results 
 
3.1 Hypoxia produces a biphasic vasomotor response which is mimicked by 
exogenous hydrogen sulfide in the coronary artery 
In the porcine isolated coronary artery, hypoxia (95% N2, 5% CO2; measured oxygen 
tension of 30 µM) caused a biphasic response (Figure 1A) consisting of an initial 
transient contraction, followed by a prolonged and pronounced vasorelaxation. A 
biphasic response (Figure 1B,C), contraction at 1-100 µM and relaxation at 300-1000 
µM, was also seen upon application of the H2S salts; Na2S and NaHS.  
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3.2 Three hydrogen sulfide synthesising enzymes, CSE, CBS and MPST are 
expressed in the coronary artery  
Using antibodies we have previously characterized for cross-reactivity with porcine 
enzymes [25], immunoblot analysis showed that all three enzymes CBS (63 kDa), 
CSE (44 kDa) and MPST (33 kDa) are present within the porcine coronary artery 
(using actin (45 kDa) as a control to normalise for protein level variation) (n=4) 
(Figure 2A). Full blots are given in Online resource 1. Immunoblot analysis also 
showed the presence of CBS in cultured porcine and human coronary artery smooth 
muscle cells but the expression of CBS enzymes in cultured tissue was much reduced 
(only 12-15% compared to intact porcine coronary arteries) (Online resource 2).  
 
Immunohistochemistry (Figure 2B) showed that CBS, CSE and MPST are located 
within the coronary artery. CBS and CSE staining appeared dispersed throughout the 
smooth muscle and endothelium, however MPST staining was more punctate, 
appearing at the base of the endothelium and within discrete regions of the smooth 
muscle. Immunocytochemical staining of cultured porcine coronary artery smooth 
muscle cells showed cytoplasmic colocalisation of CBS and α-actin (Figure 2C).   
 
3.3 The contractile phase of the response to both hypoxia and exogenous 
hydrogen sulfide involves endothelial nitric oxide  
The hypoxic contraction was significantly inhibited following endothelium removal, 
in the presence of the NOS inhibitor, N
ɷ
-nitro-L-arginine methyl ester (L-NAME, 100 
µM), and in the presence of a soluble guanylyl cyclase inhibitor [1H-
[1,2,4]oxadiazol[4,3,a]quinoxaline-1-one] (ODQ, 10 µM) (Figure 3A,C,E, Table 1), in 
agreement with previous studies [15]. Similarly, the contractile response to the H2S 
salts, Na2S and NaHS (1-100 µM) was abolished in endothelium denuded vessels and 
in the presence of L-NAME or ODQ (Figure 4A-F).  
 
3.4 The relaxation phase of the response to both hypoxia and exogenous 
hydrogen sulfide is endothelium-independent, and involves K
+
 channels and Cl
-
/HCO3
-
 exchange  
3.4.1 Involvement of NO 
The hypoxic relaxation was unaltered in endothelium-denuded vessels and in the 
presence of ODQ (Figure 3B,F, Table 1). However in the presence of L-NAME (100 
µM), the contractile phase was absent with a shorter latency of the relaxation phase 
which was significantly increased, indicative of functional antagonism (Figure 3C, 
3D, Table 1). Thus, when the contractile phase of the response is inhibited, the 
relaxation phase is augmented suggesting that they are at least partly coincident. 
Relaxatory effects elicited by the H2S salt Na2S were also increased by 
pharmacological interference with NO signalling (L-NAME and ODQ), and by 
removal of the endothelium, also indicative of functional antagonism (Figure 4A-F, 
Table 2). Relaxatory effects of NaHS were also increased by ODQ, but not by L-
NAME or endothelium removal (Table 2). 
 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 9 of 37 
 
3.4.2 Involvement of potassium channels  
Pretreatment with 50 mM KCl significantly reduced both the hypoxia-induced 
contraction and relaxation (Table 1). However, the non-selective K
+
 channel blocker 
tetraethylammonium (TEA) had no effect on the response to hypoxia at 1 mM TEA, 
but caused a significant increase in the contractile phase when used at 10 mM (Table 
1). Similarly, a combination of K
+
 channel blockers; glibenclamide (10 µM), 
charybdotoxin (ChTX 10 nM), apamin (100 nM), 4-aminopyridine (4-AP 1 mM) and 
BaCl2 (30 µM), caused a significant increase in the hypoxia-induced contraction, but 
had no effect on relaxation (Table 1). Subtype selective K
+
 channel inhibitors for KIR 
(BaCl2) and KCa (ChTX and apamin) had no effect on the overall hypoxic response 
(Table 1). An inhibitor of KV (4-AP) caused a significant increase in the contractile 
response. The KATP channel inhibitor glibenclamide significantly increased the 
maximum relaxation induced by hypoxia (Table 1).   
 
Relaxation responses to Na2S and NaHS were also significantly attenuated in the 
presence of 50 mM KCl (Table 2). TEA (1 mM) had no effect on the concentration 
response curves to Na2S and NaHS. TEA (10 mM) abolished the contractile responses 
to Na2S and NaHS (data not shown) and shifted the curves to the left, producing 
relaxation at lower concentrations (1-100 µM) with the maximum relaxation to Na2S, 
but not NaHS, being increased compared to the control (Table 2). In the presence of a 
combination of K
+
 channel blockers, there was no effect on the concentration response 
curves of Na2S and, while the effect on the response to NaHS was significant overall, 
with the curve shifting to the left, no individual concentrations were significantly 
altered (Table 2). Blockade of KIR (BaCl2) had no effect on relaxation responses to 
NaHS, however the relaxation response to Na2S was blunted and the maximum 
response was significantly reduced (Table 2). KCa (TRAM-34 10 µM and apamin 100 
nM), KV (4-AP) and KATP (glibenclamide) channel inhibitors had no significant effect 
on the relaxation response to Na2S or NaHS (Table 2).  
 
3.4.3 Involvement of chloride channels 
A Cl
-
/HCO3
-
 exchange inhibitor DIDS (4,4-diisothiocyanatostilbene-2,2'-disulfonic 
acid, 100 µM) significantly reduced the relaxation phase of the hypoxic response 
(Table 1). In addition, DIDS significantly reduced the relaxations induced by Na2S 
and NaHS (Table 2). 
 
3.4.4 Involvement of adenylyl cyclase 
An adenylyl cyclase inhibitor, SQ 22536 (10 µM), had no significant effect on the 
hypoxic response (Table 1). SQ 22536 caused a significant leftward shift in the 
response to Na2S; however, the contractile response at 30 µM Na2S (data not shown) 
and relaxant response at 1 mM Na2S (Table 2) were not significantly different. SQ 
22536 caused no alteration in the vascular responses to NaHS (Table 2). 
 
3.5 Hydrogen sulfide production from CBS is involved in the coronary artery 
hypoxic response and dominates over CSE and MPST 
The CSE inhibitor, DL-propargylgylcine (PPG 10 µM, 30 µM, 100 µM, 1 mM) and 
the MPST pathway inhibitor, aspartate (1 mM), alone or in combination had no effect 
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on the vascular response to hypoxia (Figure 5F,G,H). The CBS inhibitor amino-
oxyacetate (AOAA) caused a significant reduction in the contractile phase at 100 µM 
(control 26 ± 4%, +AOAA 16 ± 4%, P<0.03, Figure 5A, B), and significantly reduced 
the relaxation phase of the hypoxic response at higher concentrations (control 62 ± 
5%, +300 µM AOAA 46 ± 7%, P=0.01; control 60 ± 4%, +1 mM AOAA 34 ± 5%, 
P=0.008). Further experiments in endothelium-denuded vessels demonstrated that 300 
µM AOAA had no effect on the contractile phase (Figure 5D) but significantly 
reduced the relaxation phase of the hypoxic response (P=0.01) from 56.6 ± 4.0% 
under control conditions to 28.6 ± 4.9% in the presence of AOAA (n=8) (Figure 5E). 
 
Combining PPG (10 µM) and AOAA (100 µM) caused a significant reduction in both 
the contraction (control 12 ± 2%, PPG/AOAA 6 ± 1%; P=0.0213) and the relaxation 
phase (control 62 ± 5%, PPG/AOAA 46 ± 6%; P=0.0210) of the hypoxic response 
(Figure 6A). Combinations of higher concentrations of PPG and AOAA (30 µM PPG/ 
300 µM AOAA and 100 µM PPG/ 1mM AOAA, data not shown) also significantly 
reduced both phases of the hypoxic response. A combination of aspartate (1 mM) and 
AOAA (100 µM) caused a significant reduction in the hypoxia-induced relaxation 
(control 76 ± 6%, Aspartate/AOAA 46 ± 6%, P=0.0013) (Figure 6B). Combining PPG 
(10 µM), AOAA (100 µM) and aspartate (1 mM) significantly reduced both the 
contractile (control 14 ± 2%, combination 7 ± 2%, P=0.0105) and relaxation (control 
60 ± 5%, combination 42 ± 5%, P=0.0057) phases of the hypoxic response (Figure 
6C). Calculation of area under the curve (AUC) similarly showed that 100 µM AOAA 
had no significant effect on the AUC of the relaxation response (Figure 6D), however 
the relaxation phase was significantly reduced when AOAA was combined with PPG 
(Figure 6E), aspartate (Figure 6F), or both PPG and aspartate (Figure 6G).  
 
We sought to investigate the selectivity of the enzyme inhibitors using pinacidil 
(potassium channel opener), given the evidence for an involvement of potassium 
channels in vasorelaxation to both hypoxia and H2S shown in the present study and by 
others [15,16,18]. PPG, AOAA and aspartate, alone or in combination, had no 
significant effect on vasorelaxation to pinacidil in the porcine coronary artery (see 
Online resource 3). 
 
3.6 Endogenous production of hydrogen sulfide through CBS and MPST, but not 
CSE 
Endogenous production of H2S was detected in porcine coronary arteries using the 
methylene blue method (Figure 7). Generation of H2S from these coronary samples in 
solutions containing L-cysteine and pyridoxal phosphate was effectively abolished in 
the presence of AOAA (10 µM), but not PPG (10 µM) (Figure 7A). No colorimetric 
changes were measured in blank samples (in the absence of tissue or L-cysteine). H2S 
production involving MPST activity was also measured using 3-mercaptopyruvate as 
a substrate (Figure 7B). L-cysteine produced concentration-dependent relaxation in 
coronary artery segments which was blocked by AOAA (100 µM) but not by PPG (10 
µM), consistent with an involvement of CBS in the synthesis of endogenous H2S 
(Online resource 4). 
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4. Discussion  
 
The main findings of this study are that H2S is an endogenous mediator of the hypoxic 
response in porcine coronary arteries and the most important enzyme responsible for 
H2S generation during the hypoxic response in the coronary artery appears to be CBS, 
expressed in the vascular smooth muscle. Thus, we have provided evidence of a 
patho/physiological setting within the cardiovascular system where CSE is not the 
principle H2S-synthesizing enzyme. There is some contribution to the hypoxic 
response from H2S produced by the other H2S-producing enzymes, CSE and MPST, 
which were also expressed in the coronary artery, but the contribution of these 
enzymes only becomes apparent following CBS blockade. A summary of the main 
mechanisms is shown in Figure 8. 
 
CBS is the most important H2S synthesizing enzyme involved in the coronary 
artery hypoxic response 
A combination of inhibitors of H2S synthesis attenuated coronary hypoxic 
vasorelaxation, consistent with a role of H2S in the hypoxic response, as reported in 
preliminary studies by us and others [16,26]. When the enzyme inhibitors were 
investigated individually, AOAA (CBS inhibitor) alone attenuated the hypoxic 
response, but PPG (CSE inhibitor) alone and aspartate (which inhibits CAT and 
therefore indirectly MPST activity) alone were without effect. Thus, CBS appears to 
be the most important enzyme involved in hypoxic generation of H2S in the porcine 
coronary artery. AOAA was also reported to reduce hypoxic constriction of bovine 
pulmonary arteries and hagfish aorta, but PPG was ineffective, similarly suggesting a 
predominant involvement of CBS [2,3]. In contrast, hypoxic relaxation of the rat 
thoracic aorta was essentially abolished by PPG [2] pointing to a predominant 
involvement of CSE in this tissue. Our data are in line with those of Kuo et al. who 
reported a minor role of CSE of H2S generation in mouse coronary artery; they did not 
investigate a possible involvement of CBS (or hypoxia) and concluded that MPST 
was most important [27]. These data identify fundamental differences between tissues 
and/or species with regard to which enzymes are involved in the hypoxic synthesis of 
H2S.  
 
Interestingly, we found that combinations of the inhibitors that included AOAA 
(namely AOAA plus PPG; AOAA plus aspartate; and AOAA plus PPG and 
aspartate), produced a larger (versus AOAA alone) inhibitory effect. Thus, CBS may 
compensate for inhibition of CSE and/or MPST. Reciprocal compensatory effects of 
CBS and CSE in the regulation of renal functions and urinary haemodynamics have 
similarly been observed in kidney [28]. AOAA has been shown to have limited 
selectivity for CSE [29,30]; however, the response seen here is unlikely to involve 
CSE as the relatively selective CSE inhibitor, PPG, had no effect alone on the hypoxic 
response at concentrations up to 1 mM. None of the inhibitors, or combinations of 
inhibitors, affected pinacidil induced relaxations of the coronary artery, consistent 
with them having selective inhibitory actions at the H2S synthesizing enzymes. In line 
with these functional data, measurement of H2S formation showed that AOAA, but 
not PPG, blocked the pyridoxal phosphate-dependent generation of H2S from the 
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porcine coronary artery, indicating a direct effect on the H2S synthetic pathway, 
consistent with an involvement of CBS. In aortic and pulmonary vessel homogenates, 
production of H2S was similarly attenuated by AOAA, but not by PPG [2]. It should 
be noted, however, that AOAA can inhibit pyridoxal phosphate-dependent enzymes in 
addition to CBS [31], and can also inhibit mitochondrial malate-aspartate shuttles 
leading to an increase in the cytoplasmic NADH/NAD ratio and redox state [32], 
which may contribute to its effects. The development and use of specific CBS 
inhibitors is needed to determine its precise contribution to the coronary artery 
hypoxic response.  
 
CBS is expressed predominantly in the coronary artery smooth muscle 
We carried out experiments in endothelium-denuded coronary artery segments to 
investigate which cells (endothelial or smooth muscle) are involved in the CBS-
dependent hypoxic production of H2S. Endothelium removal had no effect on the 
hypoxic relaxation response, and in artery segments without endothelium, the hypoxic 
relaxation response was attenuated by AOAA. These data point to CBS within smooth 
muscle as the most significant contributor of H2S to hypoxic relaxation of the porcine 
coronary artery. Our antibody-based studies in cultured cells confirmed the expression 
of CBS in porcine coronary artery smooth muscle cells, and we also observed 
expression of CBS in cultured human coronary artery smooth muscle cells by the 
same method (Online resource 2). Our data show for the first time the expression of 
CBS in the coronary vasculature, and identify a role for vascular smooth muscle CBS 
in the coronary arterial response to hypoxia. In contrast, the hypoxic contraction was 
greatly attenuated by endothelium removal and the small residual contraction in the 
endothelium-denuded segments was not significantly affected by AOAA. Thus, with 
regard to the hypoxic contraction, the response is endothelium-dependent (it involves 
NO, see below) and involves CBS-dependent production of H2S by the endothelium 
and/or smooth muscle.      
 
H2S as an oxygen sensor and mediator of the arterial hypoxic response 
In line with a role for endogenous H2S as a mediator of the hypoxic response, we 
found that exogenous H2S (Na2S and NaHS) produced a response which mimicked the 
response to hypoxia. The response to hypoxia was biphasic, consisting of a transient 
contraction followed by relaxation, reflecting changes in the local concentrations of 
endogenous metabolites and their actions due to changes in their 
generation/accumulation with hypoxia over time. The H2S salts, Na2S and NaHS, 
similarly produced a biphasic response; vessel contraction at low concentrations 
followed by relaxation at higher concentrations. A number of vasoactive mediators 
have been suggested to be involved in the hypoxic response, and it is likely that it is 
multifactorial. However, to the best of our knowledge, only H2S produces a vasomotor 
response that matches so precisely the biphasic profile of the hypoxic response. 
Adenosine, for example, produces only vasodilatation in the coronary artery; other 
mediators (e.g. purine nucleotides) may elicit a biphasic response, but these typically 
cause vasodilatation at low concentrations and vasoconstriction at high concentrations. 
Moreover, the same mechanisms were involved in the biphasic responses to both the 
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H2S donors and hypoxia, namely involvement of endothelial NO, K
+
 channels and Cl
-
/HOCl3
-
 exchange (discussed below).       
 
Our finding that H2S is an important endogenous mediator during a hypoxic insult is 
consistent with evidence that H2S acts as an oxygen sensor and transducer of the 
hypoxic response in rat aorta, lamprey and hagfish dorsal aorta, rat and bovine 
pulmonary arteries [2,3] and, importantly, extend these findings to the coronary 
vasculature. Olson and colleagues showed in lung tissue that H2S concentration and 
pO2 are inversely related; H2S was produced at low pO2 but was reduced as pO2 was 
increased [7]. It was proposed that under normoxic (normal pO2) conditions, H2S 
production is tightly regulated and rapidly quenched via oxidation, however in 
hypoxic conditions, where pO2 is low, oxidation and therefore conversion of H2S is 
reduced [7,33]. A reduction in H2S metabolism will increase H2S availability enabling 
it to produce its cardioprotective effects. In addition to the loss of metabolism of H2S, 
it has been suggested that CBS and CSE activities are altered depending on the redox 
environment [34,35] implying that their activity may also be governed by the 
availability of oxygen. The time course of the current study, 30 min exposure to 
hypoxia, was not sufficiently long to induce changes in expression levels of the H2S 
producing enzymes [36], but the activity of existing endogenous enzymes may well be 
altered within this time frame.     
 
Mechanisms involved in the coronary artery hypoxic response to H2S 
Analysis of the mechanisms involved in the vascular responses to hypoxia and 
exogenous H2S produced information that was broadly consistent with a role of 
endogenous H2S in the hypoxic response. Under standard oxygen conditions, 
constitutive production of NO by the endothelium contributes vasodilator tone to the 
arteries via activation of soluble guanylyl cyclase and production of cGMP. The 
contractile responses to hypoxia and the H2S salts, Na2S and NaHS, were 
endothelium-dependent and were blocked by L-NAME and ODQ, a soluble guanylyl 
cyclase inhibitor, indicating that they are mediated by hypoxia-induced suppression of 
NO synthesis [15] and NO and/or H2S signalling via cGMP, but not cAMP (SQ22536 
was without effect). Since the hypoxic contraction was also attenuated by inhibitors of 
H2S synthesis, this suggests that H2S is produced during hypoxia in the porcine 
coronary artery, and may combine with, and so inactivate, NO (through H2S-
nitrosothiol formation [37] leading to contraction, as suggested for H2S-induced 
contractions in rat aorta [38]. However, this hypothesis is complicated by evidence 
from a number of studies showing opposing interactions between NO and H2S, as well 
as additional interactions involving carbon monoxide (CO) [5,39-41], and it is likely 
that there is tight regulation, synergisms and antagonisms, between these so-called 
“gasotransmitters” [5].  
 
H2S-induced vasodilation involves a number of proposed mechanisms including the 
opening of KATP channels [9,42,43]. In the porcine coronary artery, in the presence of 
high potassium the vascular responses to hypoxia and the responses to Na2S and 
NaHS were abolished suggesting the involvement of potassium channels and a 
hyperpolarising mechanism. Glibenclamide did not attenuate the hypoxic response; 
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the hypoxic contraction was unaltered and the relaxation was greater in the presence 
of glibenclamide. Glibenclamide also did not attenuate the relaxation responses to 
Na2S and NaHS. Glibenclamide at 5 and 30 µM was shown to be an effective 
inhibitor of vasorelaxation mediated by the KATP channel opener levcromakalim in the 
porcine coronary artery [44,45], although depending on the concentration and 
conditions it can also inhibit other ion channels including Kv and L-type Ca
2+
 
channels [46-48]. Our data suggest a lack of involvement of KATP channels in 
coronary artery hypoxia/H2S-induced vasorelaxant responses. Our study also shows 
that KIR and KCa are not involved in the hypoxic response, since BaCl2, TRAM-
34/ChTX and apamin were without effect. A combination of potassium channel 
blockers, TEA and 4-AP (KV channel blocker), had no effect on the relaxation 
component of the hypoxic response, but significantly increased the hypoxic contractile 
component, suggesting that KV channels may be involved early in the hypoxic 
response. A recent study reported the specific involvement of KV7 channels in 
hypoxic coronary artery relaxation [16], and it is likely that these and other potassium 
channels are involved. The relaxations induced by hypoxia and by Na2S and NaHS, 
were significantly reduced in the presence of DIDS, suggesting that Cl
-
/HCO3
-
 
exchange channels are also involved in both the hypoxic response and the response to 
H2S donors, again consistent with a role of H2S in hypoxic coronary vasodilatation 
and a hyperpolarising effect. NaHS relaxations in rat and mouse aorta were also 
blocked by DIDS [49-51]. The mechanism may involve H2S-mediated intracellular 
acidification involving activation of the Cl
-
/HCO3
-
 exchanger leading to relaxation 
[51]. Differences observed in the susceptibilities of Na2S and NaHS to blockade by 
some of the inhibitors may be attributable to their different purities [52]; it is 
appropriate that the pharmacological profile of the more pure of the two compounds, 
Na2S [52], matched most closely with that of the hypoxic response.      
 
Limitations 
Although the collective evidence (immunohistochemistry, immunocytochemistry, 
immunoblotting, biochemistry, pharmacology) points to an involvement of H2S 
generated from CBS in the mechanism underlying hypoxic relaxation of the coronary 
artery, further studies are warranted. We were unable to use siRNA successfully in 
small arteries, possibly because of the difficulty in delivering the siRNA into multi-
layered vessels as well as the lower turnover rate in arteries compared to cells in 
culture. Although we were able to show the presence of CBS immunoreactivity in 
both porcine and human cultured coronary artery smooth muscle cells, the absence of 
a relevant acute hypoxic response in these cells meant that experiments using siRNA 
could not be carried out in the cultured cells. Regardless, this is the first (to the best of 
our knowledge) demonstration of the expression of CBS in coronary artery smooth 
muscle of pigs and humans, and evidence of a role of H2S generated from CBS in 
hypoxia in pig coronary arteries is presented. Future studies involving inhibitors more 
selective for CBS are required to further clarify the precise role of CBS in the 
coronary artery hypoxic response.       
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Conclusions 
 
These findings are the first to show that CBS, expressed in the vascular smooth 
muscle, is the most important H2S-synthesisizing enzyme involved in hypoxic 
relaxation of the coronary artery, and that this enzyme can compensate when there is 
inhibition of CSE and MPST. This is important as it challenges the widely held belief 
that CSE is the principal enzyme involved in production of H2S in the cardiovascular 
system, a conclusion which may derive from the focus on rats as experimental models. 
While pig and human hearts are anatomically very similar [53], it will be important to 
determine whether this is also the case in human. These results point to CBS as the 
principal target for future treatments designed to upregulate endogenous H2S levels, 
thus protecting the heart from hypoxia and preventing or reducing the symptoms of 
angina and heart failure.     
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Figure legends 
 
Fig. 1 Hypoxia produces a biphasic response in the porcine coronary artery that is 
mimicked by exogenous hydrogen sulfide (Na2S and NaHS). (A) Representative trace 
to illustrate the effect of hypoxia, induced using 95% N2/5% CO2, on the porcine 
coronary artery. Hypoxia caused a biphasic vascular response; transient contraction 
followed by prolonged relaxation which was reversible. (B) Representative trace to 
illustrate the effect of H2S salts, Na2S and NaHS, on the porcine coronary artery. (C) 
Concentration response profile for Na2S and NaHS (mean ± SEM n=40/38, 
respectively) 
 
Fig. 2 All three hydrogen sulfide synthesizing enzymes, CBS, CSE and MPST, are 
expressed in the porcine coronary artery. A) Immunoblot analysis of porcine coronary 
artery (n=4) showed that all 3 enzymes CBS (63 kDa), CSE (44 kDa) and MPST (33 
kDa) are present within the porcine coronary artery using actin (45 kDa) to indicate 
the level of protein. (B) Immunohistochemistry using an ABC-DAB staining showing 
the location of CBS, CSE and MPST within the coronary artery compared to control 
(no primary antibody). All panels were of equal magnification. (C) 
Immunocytochemistry of -actin (1:200 antibody dilution) (green) for confirmation of 
smooth muscle, and CBS immunoreactivity (1:200 antibody dilution) (red) in cultured 
porcine coronary artery vascular smooth muscle cells. SM- smooth muscle, EC-
endothelium 
 
Fig. 3 The biphasic hypoxic response of the coronary artery involves the endothelium, 
nitric oxide and guanylyl cyclase. Hypoxia-induced contraction was significantly 
reduced in the absence of the endothelium (A) and in the presence of L-NAME (C) 
and ODQ (E). Hypoxia-induced relaxation was unaltered in the absence of the 
endothelium (B), was significantly increased in the presence of L-NAME (D) and 
unaltered in the presence of ODQ (F). *P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001 (mean ± SEM n=8) 
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Fig. 4 The biphasic response to exogenous hydrogen sulfide (Na2S and NaHS) in the 
coronary artery is endothelium, nitric oxide and guanylyl cyclase dependent. 
Concentration response curves in response to Na2S and NaHS in the absence of the 
endothelium (A, B) and in the presence of L-NAME (C, D) and ODQ (E, F). *P<0.05, 
**P<0.01, ***P<0.001, ****P<0.0001 (mean ± SEM, n=15-24) 
 
Fig. 5 A CBS inhibitor (AOAA, amino-oxyacetate) attenuates the hypoxic response of 
the coronary artery, but a CSE inhibitor and MPST inhibition have no effect. (A) 
Representative trace showing effect of a CBS inhibitor, AOAA (100 µM), on the 
hypoxic response. (B) AOAA, at 100 µM, inhibited the contractile phase of the 
hypoxic response, *P=0.02. (C) AOAA, at 100 µM, did not affect the relaxation phase 
of the hypoxic response (mean ± SEM n=8). In endothelium denuded coronary 
arteries (D,E) the contractile phase was greatly attenuated, and AOAA, at 300 µM, 
had no further effect (D); AOAA, at 300 µM, attenuated the relaxant phase of 
endothelium-denuded segments of porcine coronary artery (mean ± SEM n=8), 
**P=0.01. Representative traces show that: (F) the CSE inhibitor D,L-
propargylgylcine (PPG, 10 µM), (G) the CAT inhibitor aspartate (1 mM) (an indirect 
inhibitor of MPST), or (H) PPG and aspartate in combination, had no effect on the 
vascular response to hypoxia (mean ± SEM n=8). The representative traces are 
aggregates of multiple data points produced by responses of coronary arteries from 8 
pigs  
 
Fig. 6 Combination of a CBS inhibitor (AOAA) together with inhibitors of CSE 
(PPG) and MPST (aspartate) has pronounced inhibitory effects on the coronary artery 
hypoxic response. The residual hypoxic response in the presence of AOAA was 
further reduced in the presence of PPG (A), aspartate (B) or both PPG and aspartate 
(C) (mean ± SEM n=8). The representative traces are aggregates of multiple data 
points produced by responses of coronary arteries from 8 pigs. Area under the 
relaxation response curve (AUC) in response to 100 µM AOAA alone (D) was not 
significantly different, however in the presence of PPG (10 µM) (E), aspartate (1 mM) 
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(F) or both PPG and aspartate (G) the relaxation phase is significantly reduced 
compared to control. *P<0.05, **P<0.01, ***P<0.001 (mean ± SEM n=8)   
 
Fig. 7 Endogenous production of hydrogen sulfide through CBS and MPST, but not 
CSE in the porcine coronary artery. H2S was produced in coronary artery samples in 
the presence of (A) 10 mM L-cysteine and 1mM pyridoxal phosphate. H2S generation 
was essentially abolished in the presence of AOAA (10 μM) but not PPG (10 μM). 
(B) Production of H2S from 3-mercaptopyruvate in porcine coronary artery. *P<0.05, 
***P<0.001 (mean ± SEM n=4-12)   
 
Fig. 8 Summary of mechanisms involved in hypoxic response of the coronary artery 
involving H2S. Under normoxic conditions, constitutive production of nitric oxide 
(NO) causes vasodilatation via generation of cGMP; levels of hydrogen sulfide (H2S) 
during normoxia are relatively small. Hypoxia produces a biphasic response in the 
coronary artery: transient endothelium-dependent contraction followed by 
endothelium-independent prolonged relaxation. The contraction may involve 
inhibition of endothelial NO by H2S generated by cystathionine-ß-synthase (CBS). 
The relaxation involves smooth muscle CBS and activation of potassium channels and 
chloride/bicarbonate exchange.    
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Figure 8 
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Table 1. The effect of pharmacological inhibitors on the mean relaxation responses to hypoxia in the porcine coronary artery. *<0.05, **<0.01, 
***<0.001   
Hypoxic contraction (% KCl) Hypoxic relaxation (% U46619) 
 Control Treatment n  Control Treatement n 
endothelium denuded 26 ± 4 10 ± 2 ** 8 endothelium 
denuded 
78 ± 4 64 ± 9 8 
L-NAME (100 μM) 18 ± 2 3 ± 1 *** 8 L-NAME (100 
µM) 
46 ± 4 60 ± 3 * 8 
SQ22536 (10 μM) 19 ± 2 17 ± 4 8 SQ22536 (10 
μM) 
73 ± 7 78 ± 5 8 
ODQ (10 μM) 12 ± 2 2 ± 1 ** 8 ODQ (10 μM) 69 ± 7 74 ± 7 8 
K
+ 
(50 mM) 20 ± 4 4 ± 1 ** 8 K
+ 
(50 mM) 84 ± 7  19 ± 2 *** 8 
TEA (1 mM) 15 ± 4 21 ± 4 8 TEA (1 mM) 49 ± 4 51 ± 5 8 
TEA (10 mM) 12 ± 3 22 ± 4 * 8 TEA (10 mM) 65 ± 6 74 ± 5 8 
Combination of K
+
 blockers 11 ± 3 32 ± 6 * 5 Combination of 
K
+
 blockers 
96 ± 3 90 ± 9 5 
Glibenclamide (10 μM) 16 ± 2 18 ± 3 8 Glibenclamide 
(10 μM) 
62 ± 8 93 ± 6* 8 
ChtX (10 nM) and apamin  
(100 nM) 
9 ± 4 18 ± 4 5 ChtX (10 nM) 
and apamin 
(100 nM) 
99 ± 14 97 ± 7 8 
4-AP (1 mM) 13 ± 2 20 ± 2 * 8 4-AP (1 mM) 57 ± 4 57 ± 5 5 
BaCl
2
 (30 μM) 16 ± 3 15 ± 3  8 BaCl
2
 (30 μM) 56 ± 11 58 ± 6 8 
DIDS (100 µM) 4 ± 2 4 ± 2  8 DIDS (100 
µM) 
109 ± 5  99 ± 5 * 8 
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Table 2. The effect of pharmacological inhibitors on the mean relaxation responses to Na2S and NaHS (at 1 mM) in the porcine coronary artery. 
*<0.05, **<0.01, ***<0.001. Treatment is compared to Control. 2-way ANOVA indicates a shift in the concentration-response curve. 
 Na
2
S relaxation (% U46619) NaHS relaxation (% U46619) 
 Control Treatment n 2-way 
ANOVA 
Control Treatment n 2-way 
ANOVA 
endothelium denuded 52 ± 5 69 ± 6 ** 23-24 **** 82 ± 5 73 ± 3 15-16 * 
L-NAME (100 μM) 60 ± 4 86 ± 5 *** 23-24 **** 82 ± 5 63 ± 5 * 15-16  
SQ22536 (10 μM) 68 ± 6 59 ± 5 15-16 ** 61 ± 8 56 ± 5 16  
ODQ (10 μM) 65 ± 4 99 ± 6 *** 23 **** 79 ± 7 87 ± 7 15-16 ** 
K
+ 
(50 mM) 62 ± 4 14 ± 3 *** 23-24 ** 82 ± 5 19 ± 4 *** 15-16 **** 
TEA (1 mM) 61 ± 7 58 ± 10 15-16  65 ± 6 62 ± 4 16  
TEA (10 mM) 52 ± 3 84 ± 5 *** 31-32 **** 82 ± 5 87 ± 6 15-16 **** 
Combination of K
+
 blockers 83 ± 6 100 ± 15 15-16  69 ± 6 86 ± 5 15-16 ** 
Glibenclamide (10 μM) 83 ± 6 73 ± 5 15-16  69 ± 6 87 ± 5 15-16  
TRAM34 (10 μM)/ 
apamin (100 nM) 
 
83 ± 6 
 
69 ± 5 
 
15-16 
  
69 ± 6 
 
64 ± 4 
 
15-16 
 
4-AP (1 mM) 75 ± 8 60 ± 7 15-16  73 ± 4 57 ± 6 15-16  
BaCl
2
 (30 μM) 75 ± 8 52 ± 4 ** 16 * 72 ± 4 69 ± 4 16  
DIDS (100 µM) 65 ± 4 8 ± 15 *** 8 * 89 ± 19 28 ± 11 
*** 
8 *** 
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